Videos

News from CPhI

Aesica says academic partnerships are key for CMOs

06-Dec-2012 By Gareth Macdonald

UK CMO Aesica Pharmaceutical says that working with academia to access cutting edge technologies is critical for contractors that want to meet the demands of the modern drug industry.

Koslow launches hand-held passivation testing tech

02-Jul-2012

A new hand-held testing device can help drugmakers determine if their stainless steel tech is prone to corrosion according to developer Koslow Scientific.

Price of water & corporate sustainability agendas pushing waste reuse; Veolia

21-Jun-2012 By Nick Taylor

The price of water and corporate agendas are driving pharmaceutical production plants to reuse and reclaim waste, Veolia said.

Freeman updates powder analysis tech

20-Jun-2012 By Natalie Morrison

Freeman Technology has added a new “intuitive” control system to its multi-purpose powder analysis system.

ATMI gears up for single-use "boom" for biotech industry

18-Jun-2012 By Natalie Morrison

ATMI has added helium integrity testing of bioprocess vessels in response to what it says is a boom in the single-use technology arena.

Wockhardt targets CMO space for diversification

14-Jun-2012 By Gareth Macdonald

Wockhardt sees the ‘fractured CMO space’ as providing opportunities for growth, diversification and greater capacity utilisation.

Mettler Toledo take track and trace offering to the US

14-Jun-2012 By Natalie Morrison

Mettler Toledo is taking its ramped-up track and trace offering to the US in a bid to plug what it says is a sizeable gap in the market.

Open pharma – regulator talks “critically important” to ending shortages; FDA

11-Jun-2012 By Nick Taylor

Biopharma firms can overcome a hurdle to ending drug shortages by having transparent talks with the FDA, an Agency official said.

Fantastic four pool together to create super suite for processing HP drugs

05-Jun-2012 By Natalie Morrison

Schenck Accurate, Malvern, PSL and Sturtevant have teamed up to create a “unique” new turnkey isolated milling suite which they say will wipe out unnecessary waiting times for high potency (HP) drug processing.

P-Gels mean cheaper and more varied drug development, says Patheon

31-May-2012 By Natalie Morrison

Patheon says its new soft gel platform is creating cheaper development opportunities for drugsmakers.

Kemwell and Boehringer set to finish biologics plant in India

29-May-2012 By Natalie Morrison

Kemwell is set to complete a new biologics manufacturing facility in Bangalore, India, following its long-term partnership with Boehringer Ingelheim.

Mergers a “key problem” for regulatory compliance, drug quality expert says

29-May-2012 By Nick Taylor

Biopharma mergers are a “key problem” for manufacturing quality teams as the loss of focus can lead to regulatory actions, a compliance expert said.

EMD Millipore stresses ease of use and flexibility benefits of new bioreactor

21-May-2012 By Gareth Macdonald

EMD Millipore premiered a new single-use bioreactor at Interphex 2012, claiming the new design addresses industry demand for ease of use and flexibility.